theme,sub_theme,topic,geography_type,geography,metric,sex,age,stratum,year,date,metric_value,in_reporting_delay_period
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-08-01,2.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-08-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-08-01,18.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-08-01,40.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-08-01,13.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-08-01,9.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-08-01,15.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-07-01,1.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-07-01,0.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-07-01,18.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-07-01,41.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-07-01,13.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-07-01,10.3500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-07-01,16.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-06-01,1.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-06-01,0.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-06-01,17.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-06-01,42.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-06-01,11.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-06-01,9.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-06-01,16.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-05-01,1.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-05-01,0.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-05-01,16.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-05-01,42.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-05-01,11.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-05-01,10.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-05-01,17.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-04-01,2.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-04-01,0.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-04-01,17.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-04-01,43.5500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-04-01,11.8600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-04-01,10.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-04-01,17.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-03-01,2.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-03-01,0.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-03-01,16.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-03-01,42.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-03-01,12.3500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-03-01,11.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-03-01,16.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-02-01,3.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-02-01,0.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-02-01,18.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-02-01,42.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-02-01,13.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-02-01,12.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-02-01,17.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-01-01,2.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-01-01,0.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-01-01,17.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-01-01,39.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-01-01,13.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-01-01,10.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-01-01,17.1800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-12-01,2.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-12-01,0.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-12-01,19.6400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-12-01,38.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-12-01,13.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-12-01,9.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-12-01,17.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-11-01,2.3500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-11-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-11-01,18.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-11-01,38.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-11-01,12.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-11-01,8.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-11-01,17.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-10-01,2.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-10-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-10-01,18.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-10-01,38.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-10-01,12.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-10-01,9.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-10-01,17.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-09-01,3.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-09-01,0.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-09-01,18.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-09-01,37.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-09-01,12.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-09-01,10.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-09-01,17.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-08-01,2.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-08-01,0.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-08-01,17.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-08-01,36.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-08-01,13.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-08-01,11.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-08-01,17.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-07-01,2.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-07-01,0.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-07-01,18.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-07-01,37.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-07-01,13.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-07-01,12.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-07-01,17.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-06-01,2.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-06-01,0.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-06-01,17.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-06-01,37.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-06-01,13.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-06-01,12.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-06-01,17.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-05-01,3.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-05-01,0.6400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-05-01,18.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-05-01,37.6600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-05-01,13.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-05-01,13.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-05-01,17.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-04-01,2.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-04-01,0.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-04-01,18.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-04-01,37.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-04-01,13.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-04-01,11.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-04-01,16.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-03-01,2.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-03-01,0.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-03-01,18.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-03-01,36.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-03-01,12.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-03-01,10.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-03-01,15.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-02-01,2.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-02-01,0.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-02-01,17.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-02-01,37.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-02-01,13.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-02-01,10.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-02-01,16.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-01-01,1.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-01-01,0.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-01-01,18.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-01-01,37.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-01-01,12.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-01-01,9.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-01-01,16.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-12-01,1.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-12-01,0.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-12-01,19.6400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-12-01,39.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-12-01,12.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-12-01,10.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-12-01,16.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-11-01,2.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-11-01,0.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-11-01,19.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-11-01,38.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-11-01,11.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-11-01,9.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-11-01,15.6800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-10-01,2.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-10-01,0.3500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-10-01,17.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-10-01,36.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-10-01,10.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-10-01,9.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-10-01,15.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-09-01,2.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-09-01,0.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-09-01,17.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-09-01,37.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-09-01,11.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-09-01,9.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-09-01,15.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-08-01,2.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-08-01,0.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-08-01,18.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-08-01,40.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-08-01,12.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-08-01,9.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-08-01,17.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-07-01,3.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-07-01,0.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-07-01,18.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-07-01,41.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-07-01,12.6200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-07-01,9.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-07-01,16.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-06-01,3.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-06-01,0.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-06-01,18.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-06-01,39.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-06-01,11.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-06-01,8.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-06-01,16.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-05-01,3.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-05-01,0.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-05-01,18.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-05-01,39.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-05-01,11.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-05-01,10.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-05-01,16.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-04-01,2.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-04-01,0.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-04-01,17.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-04-01,40.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-04-01,11.0400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-04-01,11.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-04-01,16.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-03-01,3.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-03-01,0.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-03-01,15.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-03-01,42.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-03-01,10.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-03-01,11.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-03-01,16.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-02-01,3.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-02-01,0.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-02-01,16.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-02-01,40.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-02-01,11.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-02-01,10.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-02-01,16.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-01-01,3.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-01-01,0.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-01-01,16.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-01-01,38.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-01-01,11.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-01-01,9.6200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-01-01,15.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-12-01,3.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-12-01,0.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-12-01,17.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-12-01,38.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-12-01,12.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-12-01,9.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-12-01,15.8800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-11-01,3.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-11-01,0.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-11-01,17.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-11-01,37.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-11-01,11.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-11-01,9.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-11-01,15.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-10-01,3.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-10-01,0.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-10-01,18.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-10-01,37.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-10-01,11.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-10-01,8.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-10-01,15.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-09-01,2.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-09-01,0.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-09-01,18.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-09-01,37.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-09-01,10.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-09-01,8.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-09-01,15.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-08-01,2.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-08-01,0.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-08-01,17.8600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-08-01,37.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-08-01,10.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-08-01,8.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-08-01,14.0400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-07-01,1.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-07-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-07-01,16.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-07-01,37.6400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-07-01,10.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-07-01,8.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-07-01,13.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-06-01,2.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-06-01,0.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-06-01,17.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-06-01,39.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-06-01,12.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-06-01,9.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-06-01,13.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-05-01,2.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-05-01,0.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-05-01,16.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-05-01,40.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-05-01,12.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-05-01,10.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-05-01,14.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-04-01,3.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-04-01,0.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-04-01,17.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-04-01,41.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-04-01,13.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-04-01,11.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-04-01,14.6800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-03-01,2.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-03-01,0.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-03-01,16.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-03-01,39.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-03-01,11.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-03-01,10.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-03-01,14.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-02-01,2.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-02-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-02-01,16.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-02-01,40.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-02-01,12.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-02-01,10.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-02-01,14.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-01-01,1.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-01-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-01-01,15.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-01-01,41.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-01-01,11.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-01-01,11.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-01-01,13.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-12-01,0.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-12-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-12-01,15.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-12-01,43.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-12-01,12.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-12-01,11.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-12-01,13.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-11-01,1.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-11-01,0.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-11-01,15.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-11-01,41.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-11-01,10.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-11-01,11.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-11-01,13.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-10-01,2.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-10-01,0.3000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-10-01,16.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-10-01,39.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-10-01,8.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-10-01,9.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-10-01,12.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-09-01,2.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-09-01,0.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-09-01,16.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-09-01,38.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-09-01,8.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-09-01,8.3500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-09-01,12.6200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-08-01,1.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-08-01,0.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-08-01,16.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-08-01,36.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-08-01,9.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-08-01,7.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-08-01,13.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-07-01,1.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-07-01,0.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-07-01,15.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-07-01,37.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-07-01,9.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-07-01,6.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-07-01,13.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-06-01,2.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-06-01,0.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-06-01,16.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-06-01,36.1900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-06-01,9.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-06-01,6.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-06-01,13.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-05-01,3.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-05-01,0.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-05-01,16.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-05-01,39.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-05-01,10.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-05-01,7.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-05-01,13.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-04-01,2.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-04-01,0.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-04-01,18.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-04-01,40.6800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-04-01,11.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-04-01,8.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-04-01,14.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-03-01,2.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-03-01,0.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-03-01,18.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-03-01,42.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-03-01,11.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-03-01,8.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-03-01,15.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-02-01,1.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-02-01,0.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-02-01,18.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-02-01,41.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-02-01,11.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-02-01,8.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-02-01,14.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-01-01,1.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-01-01,0.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-01-01,17.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-01-01,41.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-01-01,11.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-01-01,8.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-01-01,14.6400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-12-01,2.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-12-01,0.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-12-01,17.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-12-01,42.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-12-01,12.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-12-01,8.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-12-01,14.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-11-01,1.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-11-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-11-01,18.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-11-01,44.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-11-01,12.6400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-11-01,8.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-11-01,14.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-10-01,1.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-10-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-10-01,18.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-10-01,44.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-10-01,12.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-10-01,8.8800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,South East,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-10-01,14.4000,False
